Search results
Results from the WOW.Com Content Network
Atenolol is available in the form of 25, 50, and 100 mg oral tablets. [21] [4] It is also available in the form of oral tablets containing a combination of 50 or 100 mg atenolol and 50 mg chlortalidone. [21] Atenolol was previously available in a 0.5 mg/mL solution for injection as well, but this formulation was discontinued. [21]
The drug is considered to have a high potential for abuse and addiction, but has accepted medical use for the treatment of severe insomnia. [84] In Australia, temazepam is a Schedule 4 - Prescription Only medicine. [85] It is primarily used for the treatment of insomnia, and is also seen as pre-anaesthetic medication. [10]
Atenolol/chlorthalidone, also known as co-tenidone, is a combination medication used to treat high blood pressure. [2] [3] It is made up of atenolol, a beta-blocker and chlortalidone, a diuretic. [4] It is not recommended as an initial treatment but may be used in those who are taking atenolol and chlortalidone individually. [5] It is taken by ...
The company's stock was trading at $9.93, and including Monday's gains, was up more than 50% this year. Terns said it plans to advance the drug into mid-stage trials next year.
This is a list of investigational social anxiety disorder drugs, or drugs that are currently under development for clinical use in the treatment of social anxiety disorder (SAD; or social phobia) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.
A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...
The World Anti-Doping Agency on Monday offered an explanation for why top-ranked tennis player Jannik Sinner received a much shorter doping ban than the six-year suspension it handed to a Spanish ...
When used as drugs, the International Nonproprietary Names (INNs) end in -mab. The remaining syllables of the INNs, as well as the column Source, are explained in Nomenclature of monoclonal antibodies. Types of monoclonal antibodies with other structures than naturally occurring antibodies.